Consulta LTD Position in Nike (NKE) Decreased by $21.70 Million as Valuation Rose; Edwards Lifesciences Com (EW) Shareholder Disciplined Growth Investors Boosted Its Holding by $1.31 Million

May 26, 2018 - By Richard Conner

Edwards Lifesciences Corporation (NYSE:EW) Logo

Consulta Ltd decreased its stake in Nike Inc (NKE) by 41.18% based on its latest 2017Q4 regulatory filing with the SEC. Consulta Ltd sold 350,000 shares as the company’s stock rose 4.55% while stock markets declined. The institutional investor held 500,000 shares of the consumer non-durables company at the end of 2017Q4, valued at $31.28 million, down from 850,000 at the end of the previous reported quarter. Consulta Ltd who had been investing in Nike Inc for a number of months, seems to be less bullish one the $116.45B market cap company. The stock increased 0.10% or $0.07 during the last trading session, reaching $72.25. About 5.89M shares traded. NIKE, Inc. (NYSE:NKE) has risen 18.31% since May 26, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.

Disciplined Growth Investors Inc increased its stake in Edwards Lifesciences Corp Com (EW) by 0.55% based on its latest 2017Q4 regulatory filing with the SEC. Disciplined Growth Investors Inc bought 11,675 shares as the company’s stock rose 22.78% while stock markets declined. The institutional investor held 2.12 million shares of the industrial specialties company at the end of 2017Q4, valued at $238.51 million, up from 2.10 million at the end of the previous reported quarter. Disciplined Growth Investors Inc who had been investing in Edwards Lifesciences Corp Com for a number of months, seems to be bullish on the $28.66B market cap company. The stock decreased 1.18% or $1.62 during the last trading session, reaching $135.95. About 1.00 million shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 44.06% since May 26, 2017 and is uptrending. It has outperformed by 32.51% the S&P500.

Among 44 analysts covering Nike Inc. (NYSE:NKE), 26 have Buy rating, 2 Sell and 16 Hold. Therefore 59% are positive. Nike Inc. had 235 analyst reports since July 29, 2015 according to SRatingsIntel. Sterne Agee CRT maintained the shares of NKE in report on Thursday, September 17 with “Neutral” rating. The rating was upgraded by BB&T Capital on Monday, October 19 to “Buy”. The stock of NIKE, Inc. (NYSE:NKE) has “Overweight” rating given on Wednesday, September 27 by Morgan Stanley. The rating was maintained by DA Davidson on Wednesday, June 29 with “Buy”. As per Wednesday, June 29, the company rating was maintained by UBS. As per Thursday, March 23, the company rating was maintained by FBR Capital. DA Davidson maintained it with “Buy” rating and $78 target in Tuesday, December 26 report. The stock of NIKE, Inc. (NYSE:NKE) has “Neutral” rating given on Wednesday, September 28 by B. Riley & Co. The stock of NIKE, Inc. (NYSE:NKE) has “Hold” rating given on Friday, September 23 by Canaccord Genuity. The firm earned “Buy” rating on Friday, July 21 by Guggenheim.

More notable recent NIKE, Inc. (NYSE:NKE) news were published by: 247Wallst.com which released: “Boeing Continues as Top Performing Dow Stock” on May 26, 2018, also Bizjournals.com with their article: “A former Nike executive launches Portland’s first luxury women’s sportswear company” published on May 09, 2018, Streetinsider.com published: “Foot Locker’s Endorsement of North American Inflection Positive for Nike (NKE) – Stifel” on May 25, 2018. More interesting news about NIKE, Inc. (NYSE:NKE) were released by: Seekingalpha.com and their article: “Nike breaks to new all-time high” published on May 16, 2018 as well as Bizjournals.com‘s news article titled: “Roster change: Nike, not Under Armour, to get MLB on-field rights” with publication date: May 24, 2018.

Consulta Ltd, which manages about $846.53M US Long portfolio, upped its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 75,000 shares to 250,000 shares, valued at $47.47 million in 2017Q4, according to the filing.

Analysts await NIKE, Inc. (NYSE:NKE) to report earnings on July, 5. They expect $0.64 earnings per share, up 6.67% or $0.04 from last year’s $0.6 per share. NKE’s profit will be $1.03B for 28.22 P/E if the $0.64 EPS becomes a reality. After $0.68 actual earnings per share reported by NIKE, Inc. for the previous quarter, Wall Street now forecasts -5.88% negative EPS growth.

Since December 11, 2017, it had 0 insider purchases, and 9 sales for $49.31 million activity. SPRUNK ERIC D sold $3.50 million worth of NIKE, Inc. (NYSE:NKE) on Wednesday, May 16. 100,000 shares valued at $6.85M were sold by EDWARDS TREVOR A on Wednesday, January 31. Matheson Monique S. sold $650,000 worth of stock or 10,000 shares. PARKER MARK G sold 135,000 shares worth $8.78 million.

Investors sentiment decreased to 0.74 in 2017 Q4. Its down 0.06, from 0.8 in 2017Q3. It turned negative, as 70 investors sold NKE shares while 501 reduced holdings. 109 funds opened positions while 312 raised stakes. 1.01 billion shares or 2.95% more from 985.62 million shares in 2017Q3 were reported. Neville Rodie Shaw Inc accumulated 44,065 shares or 0.29% of the stock. Cullinan Inc owns 96,800 shares. Liberty Mutual Asset Mgmt accumulated 52,369 shares or 0.1% of the stock. Principal Financial Gru accumulated 2.15 million shares. Waters Parkerson Company Ltd Liability Company has invested 1.98% in NIKE, Inc. (NYSE:NKE). Farmers Savings Bank stated it has 0.09% of its portfolio in NIKE, Inc. (NYSE:NKE). 69,000 are owned by Employees Retirement Systems Of Texas. Plancorp Limited Co holds 0.17% or 8,364 shares. Savant Cap Ltd Llc holds 5,252 shares or 0.07% of its portfolio. Liberty Cap owns 400 shares or 0.01% of their US portfolio. Ibm Retirement Fund owns 0.41% invested in NIKE, Inc. (NYSE:NKE) for 35,328 shares. Adell Harriman Carpenter invested 0.14% of its portfolio in NIKE, Inc. (NYSE:NKE). 2,349 are held by Howe Rusling. Canandaigua Comml Bank & Tru invested 0.3% of its portfolio in NIKE, Inc. (NYSE:NKE). Guardian Capital Lp invested in 0.01% or 11,699 shares.

More recent Edwards Lifesciences Corporation (NYSE:EW) news were published by: Seekingalpha.com which released: “Edwards Lifesciences: Treating The #1 Killer In America” on May 12, 2018. Also Profitconfidential.com published the news titled: “Despite the Sell-Off, Edwards Life Sciences Stock Still Remains Bullish” on April 30, 2018. Streetinsider.com‘s news article titled: “Edwards Lifesciences (EW) Says Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With its …” with publication date: May 22, 2018 was also an interesting one.

NIKE, Inc. (NYSE:NKE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>